Website News and Research

RSS

Viropharma announces financial results for second quarter of 2013

VIROPHARMA INCORPORATED (Nasdaq: VPHM) today announced financial results for the second quarter of 2013. Net sales were $104 million for the second quarter ended June 30, 2013 as compared to $95 million in the comparative period of 2012.

1 Aug 2013

BD reports quarterly revenues of $2.053 billion for third fiscal quarter

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.053 billion for the third fiscal quarter ended June 30, 2013, representing an increase of 3.6 percent from the prior-year period, or 5.1 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 1 Aug 2013

Georgia seeks 'emergency delay' for approving health exchanges' proposed rates

The state insurance commissioner cited "massive rate increases" in the proposals from seven insurers seeking to do business on these online insurance marketplaces.

1 Aug 2013

NIH-funded study finds that rituximab is as effective as standard therapy for severe vasculitis

Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study has found.

1 Aug 2013

Fewer states holding alcohol retailers liable for harms caused by customers who were served illegally

Fewer states are holding alcohol retailers liable for harms caused by customers who were served illegally, according to a new report from researchers at Alcohol Policy Consultations and the Center on Alcohol Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg School of Public Health.

31 Jul 2013

New treatment options give hope to people with psoriasis

Psoriasis expert and researcher Steve Feldman, M.D., says there are many new treatment options giving hope to the millions of people who suffer from the chronic skin condition.

31 Jul 2013

Science Exchange partners with antibodies-online to independently validate antibodies to improve research quality

Science Exchange, in partnership with the world's largest marketplace for antibodies, antibodies-online, announced today the launch of a program to independently validate thousands of commercial antibodies via the Science Exchange independent validation service.

31 Jul 2013

Tick-borne diseases on the rise in US

With the summer months upon us, Lyme disease and other tick-borne illnesses are on the rise in the United States. According to the U.S. Centers for Disease Control and Prevention, tick-borne diseases are increasing, with human cases expected to exceed 300,000 annually.

30 Jul 2013

Researchers discover solution to long-standing medical mystery in Huntington's disease

Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD). HD is a brain disease that can affect 1 in about 7,000 people in mid-life, causing an increasing loss of brain cells at the centre of the brain.

30 Jul 2013

Technique for developing more targeted drugs using molecular "robots"

Many drugs such as agents for cancer or autoimmune diseases have nasty side effects because while they kill disease-causing cells, they also affect healthy cells. Now a new study has demonstrated a technique for developing more targeted drugs, by using molecular "robots" to hone in on more specific populations of cells.

29 Jul 2013

Leapfrog unveils new tool that allows purchasers to calculate money spent on medical errors

During a time of flux for U.S. health care, employers and purchasers are increasingly concerned about how much value they receive for their enormous investment in health care. In a presentation yesterday evening at the World Health Congress Innovative Drivers of Value Based Purchasing Seminar, Leah Binder, president and CEO of the employer-driven nonprofit The Leapfrog Group, unveiled a new tool that allows purchasers to calculate how much they spend annually on unnecessary costs due to medical errors that occur within general acute care hospitals.

26 Jul 2013

Ovary removal during hysterectomy protects against future risk of ovarian cancer

While ovary removal during hysterectomy protects against future risk of ovarian cancer, the decision to conserve the ovaries and the hormones they produce may have advantages for preventing heart disease, hip fracture, sexual dysfunction, and cognitive decline.

26 Jul 2013

Study: Heart disease emerges as number one killer among Indians

Heart disease has emerged as the number one killer among Indians, according to a recent study by the Registrar General of India ( RGI) and the Indian Council of Medical Research (ICMR).

25 Jul 2013

Star power enlisted to spread the word about health law

The Obama administration is using the help of celebrities, including comedian Amy Poehler, actor Kal Penn and singer Jennifer Hudson, to educate young Americans about new insurance options under the law.

24 Jul 2013

BD Saf-T-Intima Safety Integrated IV Catheter System gets European approval for subcutaneous infusion therapy

BD (Becton, Dickinson and Company), a leading global medical technology company, announces the approval of the BD Saf-T-Intima Safety Integrated IV Catheter System for use in subcutaneous infusion therapies in Europe.

From BD (Becton, Dickinson and Company) 23 Jul 2013

MAXIMUS signs new contract to provide support services for California's health insurance exchange

MAXIMUS, a leading provider of government services worldwide, announced that it has signed a new contract with the California Health Benefit Exchange to provide support services for the state's health insurance exchange, known as Covered California.

23 Jul 2013

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Presently, it is a diagnosis of exclusion. Patients end up spending, according to what’s been published in the medical literature, as many as 3 - 5 years going from doctor to doctor seeking a diagnosis because they tend to have nonspecific symptoms of a subjective nature.

23 Jul 2013

First Edition: July 22, 2013

Today's headlines include reports about the continuing efforts in opposition to the health law as well as a Washington Post investigation into a "flaw" in U.S. health care pricing.

22 Jul 2013

Study reveals that Hudson River polluted with antibiotic-resistant bacteria

The risk of catching some nasty germ in the Hudson River just started looking nastier. Disease-causing microbes have long been found swimming there, but now researchers have documented antibiotic-resistant strains in specific spots, from the Tappan Zee Bridge to lower Manhattan.

22 Jul 2013

Experts to focus on health care challenges at U.S. Conference on Rare Diseases and Orphan Products

Patient advocates, industry leaders, medical researchers, government officials, and investors will join together in Bethesda, MD, on Oct. 7 - 9 for the 3rd annual U.S. Conference on Rare Diseases and Orphan Products.

20 Jul 2013

Website News and Research

Viropharma announces financial results for second quarter of 2013

BD reports quarterly revenues of $2.053 billion for third fiscal quarter

Georgia seeks 'emergency delay' for approving health exchanges' proposed rates

NIH-funded study finds that rituximab is as effective as standard therapy for severe vasculitis

Fewer states holding alcohol retailers liable for harms caused by customers who were served illegally

New treatment options give hope to people with psoriasis

Science Exchange partners with antibodies-online to independently validate antibodies to improve research quality

Tick-borne diseases on the rise in US

Researchers discover solution to long-standing medical mystery in Huntington's disease

Technique for developing more targeted drugs using molecular "robots"

Leapfrog unveils new tool that allows purchasers to calculate money spent on medical errors

Ovary removal during hysterectomy protects against future risk of ovarian cancer

Study: Heart disease emerges as number one killer among Indians

Star power enlisted to spread the word about health law

BD Saf-T-Intima Safety Integrated IV Catheter System gets European approval for subcutaneous infusion therapy

MAXIMUS signs new contract to provide support services for California's health insurance exchange

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

First Edition: July 22, 2013

Study reveals that Hudson River polluted with antibiotic-resistant bacteria

Experts to focus on health care challenges at U.S. Conference on Rare Diseases and Orphan Products

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News